Kanabo Research is an R&D company based in Israel that innovates cutting edge solutions for the medical cannabis industry. Kanabo focuses on building medically validated IP that includes delivery systems working in synergy with applications of patented formulations. Initial product development is focused on vaporization, including both medical grade vaporizers and formulations of medical cannabis extracts. Clinical validation activities including safety and efficacy tests are conducted in Israel for all technology and formulations under development.
Kanabo Research was born out of Founder and CEO Avihu Tamir’s personal experience working with medical cannabis patients in Israel. In Israel, a medical cannabis patient is often directed to smoke his or her prescription – or even mix it with tobacco to ‘make it burn better.’ Concerned about the long-term health effects of smoking, and especially smoking tobacco, Avihu began exploring and providing healthier routes of administration for Israeli cannabis patients.
After deciding to initially focus on vaporization solutions, Avihu found that there were no medical vaporizers for cannabis patients available on the market. He started to change this by importing vaporizers for Israeli medical cannabis patients. Avihu has now worked with hundreds of patients over the last several years to provide training, consultation, and support for medical cannabis vaporization solutions.
Kanabo Research takes this work even further – seeking to fill a gap in the market for both medically certified vaporizers along with medically validated formulations of cannabis extracts. Kanabo is dedicated to developing safer, accessible, and medical grade alternatives for medical cannabis patients in Israel and around the world.
Kanabo Research strives to provide patients with precise, consistent, and trusted medical cannabis solutions through the development and medical validation of innovative, medical grade delivery systems that work in synergy with targeted formulations of medical cannabis extracts.
“Kanabo means cannabis in Esperanto, the language constructed in the 19th century as a means of international communication. The goal of Esperanto was to find a means of overcoming the natural indifference of people to bring humankind together. That concept of fellowship and hope inspires and drives Kanabo Research activities.”